Lactoferrin-endothelin-1 axis contributes to the development and invasiveness of triple-negative breast cancer phenotypes

Cancer Research

Volumn 71, Issue 23, 2011, Pages 7259-7269

  Ha, Ngoc Han ^a   Nair, Vasudha S ^a   Reddy, Divijendra Natha Sirigiri ^a   Mudvari, Prakriti ^a   Ohshiro, Kazufumi ^a   Ghanta, Krishna Sumanth ^a   Pakala, Suresh B ^a   Li, Da Qiang ^a   Costa, Luis ^b,d   Lipton, Allan ^e   Badwe, Rajendra A ^b,f   Fuqua, Suzanne ^g   Wallon, Margaretha ^c   Prendergast, George C ^c   Kumar, Rakesh ^a,b  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c LANKENAU INSTITUTE FOR MEDICAL RESEARCH   (United States)

^d HOSPITAL DE SANTA MARIA   (Portugal)

^e PENN STATE COLLEGE OF MEDICINE   (United States)

^f TATA MEMORIAL HOSPITAL   (India)

^g BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR ALPHA; LACTOFERRIN; POLYPEPTIDE; PROGESTERONE RECEPTOR; PROTEASOME; RECEPTOR BLOCKING AGENT; TAMOXIFEN; TRASTUZUMAB;

ARTICLE; BREAST CARCINOGENESIS; CANCER CELL; CANCER INHIBITION; CANCER INVASION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; RECEPTOR DOWN REGULATION; TRANSCRIPTION INITIATION; TRIPLE NEGATIVE BREAST CANCER;

BREAST NEOPLASMS; CACO-2 CELLS; CELL LINE, TUMOR; CELL MOVEMENT; DOWN-REGULATION; ENDOTHELIN-1; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; LACTOFERRIN; NEOPLASM INVASIVENESS; PHENOTYPE; PROTEASOME ENDOPEPTIDASE COMPLEX; RECEPTOR, ENDOTHELIN A; RECEPTOR, ERBB-2; RECEPTORS, PROGESTERONE; RNA PROCESSING, POST-TRANSCRIPTIONAL;

EID: 82655189563     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-1143     Document Type: Article

References (33)

1. Carey L, Winer E, Viale G, Cameron D, Gianni L. Triple-negative breast cancer: disease entity or title of convenience? Nat Rev Clin Oncol 2010;12:683-92.
2. Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res 2007;15:4429-34. (Pubitemid 47219710)
3. Rakha EA, El-Sayed ME, Green AR, Lee AH, Robertson JF, Ellis IO. Prognostic markers in triple-negative breast cancer. Cancer 2007;1:25-32. (Pubitemid 46120191)
4. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001;19:10869-74. (Pubitemid 32878711)
5. van 'tVeer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002;6871:530-6. (Pubitemid 34130608)
6. Teng CT. Lactoferrin: the path from protein to gene. Biometals 2010;3:359-64.
7. Campbell T, Skilton RA, Coombes RC, Shousha S, Graham MD, Luqmani YA. Isolation of a lactoferrin cDNA clone and its expression in human breast cancer. Br J Cancer 1992;1:19-26.
8. Das SK, Tan J, Johnson DC, Dey SK. Differential spatiotemporal regulation of lactoferrin and progesterone receptor genes in the mouse uterus by primary estrogen, catechol estrogen, and xenoestrogen. Endocrinology 1998;6:2905-15. (Pubitemid 28512403)
9. Penco S, Caligo MA, Cipollini G, Bevilacqua G, Garre C. Lactoferrin expression in human breast cancer. Cancer Biochem Biophys 1999;1-2:163-78. (Pubitemid 29475256)
10. Walmer DK, Padin CJ, Wrona MA, Healy BE, Bentley RC, Tsao MS, et al. Malignant transformation of the human endometrium is associated with overexpression of lactoferrin messenger RNA and protein. Cancer Res 1995;5:1168-75.
11. Stokes K, Alston-Mills B, Teng C. Estrogen response element and the promoter context of the human and mouse lactoferrin genes influence estrogen receptor alpha-mediated transactivation activity in mammary gland cells. J Mol Endocrinol 2004;2:315-34. (Pubitemid 39429561)
12. Teng CT. Factors regulating lactoferrin gene expression. Biochem Cell Biol 2006;3:263-7. (Pubitemid 44341299)
13. Grant K, Loizidou M, Taylor I. Endothelin-1: a multifunctional molecule in cancer. Br J Cancer 2003;2:163-6.
14. Oh SM, Hahm DH, Kim IH, Choi SY. Human neutrophil lactoferrin transactivates the matrix metalloproteinase 1 gene through stress-activated MAPK signaling modules. J Biol Chem 2001;276:42575-9.
15. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;6163:411-5. (Pubitemid 18090241)
16. Nelson J, Bagnato A, Battistini B, Nisen P. The endothelin axis: emerging role in cancer. Nat Rev Cancer 2003;2:110-6. (Pubitemid 37328878)
17. Spinella F, Garrafa E, Di Castro V, Rosano L, Nicotra MR, Caruso A, et al. Endothelin-1 stimulates lymphatic endothelial cells and lymphatic vessels to grow and invade. Cancer Res 2009;6:2669-76.
18. Wülfing P, Diallo R, Kersting C, Wülfing C, Poremba C, Rody A, et al. Expression of endothelin-1, endothelin-A, and endothelin-B receptor in human breast cancer and correlation with long-term follow-up. Clin Cancer Res 2003;11:4125-31. (Pubitemid 37204029)
19. Duarte DC, Nicolau A, Teixeira JA, Rodrigues LR. The effect of bovine milk lactoferrin on human breast cancer cell lines. J Dairy Sci 2011;94:66-76.
20. Davenport AP. International Union of Pharmacology. XXIX. Update on endothelin receptor nomenclature. Pharmacol Rev 2002;2:219-26. (Pubitemid 34575711)
21. Benigni A, Remuzzi G. Endothelin antagonists. Lancet 1999;9147:133-8. (Pubitemid 29088093)
22. Ihara M, Noguchi K, Saeki T, Fukuroda T, Tsuchida S, Kimura S, et al. Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sci 1992;4:247-55.
23. Remuzzi G, Perico N, Benigni A. New therapeutics that antagonize endothelin: promises and frustrations. Nat Rev Drug Discov 2002;12:986-1001. (Pubitemid 37361604)
24. Mason DY, Taylor CR. Distribution of transferrin, ferritin, and lactoferrin in human tissues. J Clin Pathol 1978;4:316-27. (Pubitemid 8315980)
25. Farley J, Loup D, Nelson M, Mitchell A, Esplund G, Macri C, et al. Neoplastic transformation of the endocervix associated with downregulation of lactoferrin expression. Mol Carcinog 1997;20:240-50. (Pubitemid 27508888)
26. Schulz DM, Bollner C, Thomas G, Atkinson M, Esposito I, Hofler H, et al. Identification of differentially expressed proteins in triple-negative breast carcinomas using DIGE and mass spectrometry. J Proteome Res 2009;7:3430-8.
27. Carducci MA, Padley RJ, Breul J, Vogelzang NJ, Zonnenberg BA, Daliani DD, et al. Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: a randomized, phase II, placebo-controlled trial. J Clin Oncol 2003;4:679-89. (Pubitemid 46621903)
28. Bagnato A, Tecce R, DiCastro V, Catt KJ. Activation of mitogenic signaling by endothelin-1 in ovarian carcinoma cells. Cancer Res 1997;57:1306-11. (Pubitemid 27152556)
29. Pedram A, Rasandi M, Hu RM, Levin ER. Vasoactive peptides modulate vascular endothelial cell growth factor production and endothelin cell proliferation and invasion. J Biol Chem 1997;272:17097-103. (Pubitemid 27289818)
30. Rosanò L, Varmi M, Salani D, Di Castro V, Spinella F, Natali PG, et al. Endothelin-1 induces tumor proteinase activation and invasiveness of ovarian carcinoma cells. Cancer Res 2001;61:8340-6. (Pubitemid 33091630)
31. Salani D, Di Castro V, Nicotra MR, Rosanò L, Tecce R, Venuti A, et al. Role of endothelin-1 in neovascularization of ovarian carcinoma. Am J Pathol 2000;157:1537-47.
32. Nelson JB, Chan-Tack K, Hedican SP, Magnuson SR, Opgenorth TJ, Bova GS, et al. Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer. Cancer Res 1996;56:663-8. (Pubitemid 26059878)
33. Cruz A, Parnot C, Ribatti D, Corvol P, Gasc JM. Endothelin-1, a regulator of angiogenesis in the chick chorioallantoic membrane. J Vasc Res 2001;38:536-45. (Pubitemid 33151593)